Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model
From MaRDI portal
Publication:827799
DOI10.1016/J.JTBI.2020.110295zbMATH Open1455.92029OpenAlexW3018290525WikidataQ93228820 ScholiaQ93228820MaRDI QIDQ827799FDOQ827799
Authors: Tatsuya Kurusu, Kwang Su Kim, Yoshiki Koizumi, Shinji Nakaoka, Keisuke Ejima, Naoko Misawa, Yoshio Koyanagi, Kei Sato, Shingo Iwami
Publication date: 13 January 2021
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2020.110295
Recommendations
- A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins
- HIV infection dynamics and viral rebound: modeling results from humanized mice
- Quantifying antiviral effects against simian/human immunodeficiency virus induced by host immune response
- Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection
- Mathematical Analysis of HIV-1 Dynamics in Vivo
Cited In (2)
This page was built for publication: Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q827799)